en fr

Advising Atrya in connection with the sale of its subsidiary Soprofen to Bouyer Leroux group

15.10.2018 · Press releases

Competition - Merger control - Distribution

Mergers and Acquisitions
Employment Law
Corporate - M&A - Private Equity
Employment Law
Corporate - M&A - Private Equity
Corporate and private equity tax law
Intellectual Property and personal data
Mergers and Acquisitions
Tax
Tax
Intellectual Property and personal data

Home > Advising Atrya in connection with the sale of its subsidiary Soprofen to Bouyer Leroux group

Advising Atrya, one of the European leaders in the manufacturing of windows, in connection with the sale of its subsidiary Soprofen, the third leading player in the conception and manufacturing of residential rolling shutters and garage doors in France, to Bouyer Leroux group.

Soprofen employs more than 400 people over 9 sites located in France and Belgium, and expects to reach c. €120m of net sales in 2018.